Search
Powered By HealthLine
Health Tools
 Mammogram Guide
 Check A Breast Cancer Symptom
 Understanding Skin Cancer
 Skin Cancer Q&A
 Prostate Cancer Treatment
Featured Conditions
 Breast Cancer
 Skin Cancer
 Prostate
 Diet & Exercise
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Informed Women Unlikely to Take Tamoxifen

Ivanhoe Broadcast News


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Amenorrhea
Amniocentesis
Amniocentesis and CVS
More...

Related Healthscout Videos
 border=
Baby Steps: Fertility Findings
Tumor Detecting App: Medicine's Next Big Thing?
Powerful Combo Reducing Lymphedema
Fighting Breast Cancer on Your Lunch Break
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Colon Cancer
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Detrol LA
Diflucan
Ditropan XL
More...

Related News Articles
 border=
New Stool Test Might Aid in Early Detection of Colon Cancer
Prenatal Antipsychotic Drugs Linked to Motor Delays: Study
Coffee Drinking in Pregnancy Won't Lead to Sleepless Baby: Study
1 in 5 Pharmacies Hinders Teens' Access to 'Morning-After' Pill: Study
More...

By Kirsten Houmann, Ivanhoe Health Correspondent

(Ivanhoe Newswire) -- While as many as 10 million women could be eligible to take the drug tamoxifen to prevent breast cancer, side effects like hot flashes, sexual problems and blood clots discourage many from taking the step.

Text Continues Below



A new study suggests women at high risk for breast cancer who are informed about the risks and benefits of using the drug tamoxifen for breast cancer prevention aren't likely to choose to take the drug.

Researchers at the University of Michigan gave study participants -- all women at high risk for breast cancer -- a decision aid that contained objective information about the risks and benefits of tamoxifen that was tailored to each woman's health history.

"They knew what their risks were if they did nothing, and then we told them, here's how likely all these things are if you take this pill," Peter Ubel, M.D., professor of medicine at the University of Michigan, told Ivanhoe.  "We went to extraordinary lengths, and why? Because I think this is probably the standard for how we should help people make difficult decisions."

After viewing the information, 41 percent of women could correctly answer six of six questions about the risks and benefits of the drug, and 63 percent correctly answered at least five questions. Results show 29 percent of women said they were likely to seek out more information about tamoxifen, 29 percent said they would ask their doctor about the drug and only 6 percent said they were likely to take it.

Three months later, researchers found fewer than 1 percent of participants had started taking tamoxifen. Eighty percent of participants said they were worried about side effects.

"There are 10 million women whose risk of breast cancer is high enough in the next five years that this is an option for them," Dr. Ubel said. "If you are one of these 10 million women you owe it to yourself to understand the risks and benefits of these drugs, and decide whether the benefits, for you, outweigh the risks."

Source: Breast Cancer Research and Treatment, December 2009



If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Melissa Medalie at mmedalie@ivanhoe.com

This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.




Last updated 12/7/2009

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2013. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire